Genoss Co., Ltd.

18 clinical trials · Sponsor

Record	Firm	Date
Clinical Outcomes of GENOSS PCB for Femoropopliteal Artery Disease (NCT07399080)	Genoss Co., Ltd.	2025-07-01
One-Year Results of GENOSS PCB Real-World Study in Femoropopliteal Artery Disease (NCT07431437)	Genoss Co., Ltd.	2025-06-17
The Safety and Efficacy for In-segment Late Lumen Loss of the 'Genoss® SCB' Versus 'SeQuent® Please NEO' in Patients With Coronary ISR (NCT07159087)	Genoss Co., Ltd.	2025-02-19
Safety and Efficacy of GENOSS® DCB With a Shellac Plus Vitamin E Excipient in Patients With De Novo Lesion (NCT07158307)	Genoss Co., Ltd.	2024-06-27
Safety and Effectiveness of GENOSS® DES in Patients With Multivessel Coronary Artery Disease (NCT06168305)	Genoss Co., Ltd.	2023-11-15
Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis (NCT06066450)	Genoss Co., Ltd.	2023-07-07
Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES) (NCT06086496)	Genoss Co., Ltd.	2022-07-15
Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure (NCT06075433)	Genoss Co., Ltd.	2022-05-13
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions (NCT05096442)	Genoss Co., Ltd.	2021-09-30
Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease (NCT06075420)	Genoss Co., Ltd.	2021-08-18
Compare the Safety and Effectiveness of Genoss® DCB and SeQuent® Please NEO in Chinese Patients with Coronary ISR (NCT04767022)	Genoss Co., Ltd.	2021-01-30
Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS) (NCT06075368)	Genoss Co., Ltd.	2020-03-16
Compare the Effectiveness and Safety of Genoss® DCB and IN.PACT Admiral® DCB in Patients With Peripheral Artery Disease (NCT05134545)	Genoss Co., Ltd.	2019-03-24
Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease (NCT06841510)	Genoss Co., Ltd.	2018-04-19

Track Genoss Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.